Contact Us
T: (212) 363-7500
F: (212) 363-7171
Copyright ©2011 Levi & Korsinsky, LLP
New York
Washington, DC
| Invacare Corporation |
| Invacare Corporation (NYSE: IVC) shareholder litigation in connection with FDA investigation |
Levi & Korsinsky is investigating potential claims on
behalf of purchasers of Invacare Corporation
(“Invacare” or the “Company”) (NYSE: IVC)
securities concerning possible violations of federal
securities laws.
behalf of purchasers of Invacare Corporation
(“Invacare” or the “Company”) (NYSE: IVC)
securities concerning possible violations of federal
securities laws.
On December 8, 2011, shares of Invacare plunged over 25% on heavy volume after the Company
revealed that U.S. health regulators have proposed the suspension of certain operations at the
medical equipment maker's corporate office and its wheelchair manufacturing facility in Elyria,
Ohio. The Food and Drug Administration (“FDA”) proposed a consent decree requiring the work
shutdown based on violations found during inspections. Operations will not resume until the FDA
concludes Invacare is in compliance with the FDA’s regulations.
revealed that U.S. health regulators have proposed the suspension of certain operations at the
medical equipment maker's corporate office and its wheelchair manufacturing facility in Elyria,
Ohio. The Food and Drug Administration (“FDA”) proposed a consent decree requiring the work
shutdown based on violations found during inspections. Operations will not resume until the FDA
concludes Invacare is in compliance with the FDA’s regulations.
